These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1590227)

  • 1. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction.
    Rodriguez LM; Smeets J; O'Hara GE; Geelen P; Brugada P; Wellens HJ
    Am J Cardiol; 1992 Jun; 69(17):1403-6. PubMed ID: 1590227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
    Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
    Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction.
    Rodriguez LM; Oyarzun R; Smeets J; Brachmann J; Schmitt C; Brugada P; Geelen P; Lipcsei G; Albert A; Wellens HJ
    Am J Cardiol; 1992 Feb; 69(5):462-4. PubMed ID: 1736607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
    Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
    Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
    Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction.
    Kron IL; Lerman B; DiMarco JP
    Ann Thorac Surg; 1986 Jul; 42(1):13-6. PubMed ID: 3729611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents.
    Constantin L; Martins JB; Kienzle MG; Brownstein SL; McCue ML; Hopson RC
    Pacing Clin Electrophysiol; 1989 May; 12(5):776-83. PubMed ID: 2471163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.
    Andresen D; Steinbeck G; Brüggemann T; Haberl R; Fink L; Schröder R
    Am J Cardiol; 1992 Nov; 70(15):1250-4. PubMed ID: 1442574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients.
    Chen X; Shenasa M; Borggrefe M; Block M; Hindricks G; Martinez-Rubio A; Haverkamp W; Willems S; Böcker D; Mäkijärvi M
    Eur Heart J; 1994 Jan; 15(1):76-82. PubMed ID: 8174587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS; Marchlinski FE; Buxton AE; Doherty JU; Waxman HL; Josephson ME
    Circulation; 1984 Sep; 70(3):451-6. PubMed ID: 6744550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS; Uricchio F; Estes NA
    Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C; Kühlkamp V; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.